Sun Pharmaceutical Industries Ltd.

The revenue declined to Rs. 50962.10 millions for the quarter ended September 2023 as compared to Rs. 52852.90 millions during the corresponding quarter last year.Net profit declined -26.74% to Rs. 8886.30 millions from Rs. 12130.10 millions.A decline of 14928.60 millions was observed in the OP in the quarter ended September 2023 from 17048.80 millions on QoQ basis.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202309	202209	% Var	202309	202209	% Var	202303	202203	% Var
Sales	50962.10	52852.90	-3.58	95622.80	102181.70	-6.42	208121.40	155859.80	33.53
Other Income	1159.30	417.10	177.94	2794.70	2179.20	28.24	3292.90	11968.80	-72.49
PBIDT	14928.60	17048.80	-12.44	26051.60	32035.30	-18.68	67518.90	38654.40	74.67
Interest	1936.30	927.70	108.72	3515.70	1798.40	95.49	4721.80	3881.00	21.66
PBDT	12992.30	16121.10	-19.41	21043.80	30236.90	-30.40	33419.20	16568.10	101.71
Depreciation	3927.10	3839.50	2.28	8079.80	7584.50	6.53	16008.70	13499.50	18.59
PBT	9065.20	12281.60	-26.19	12964.00	22652.40	-42.77	17410.50	3068.60	467.38
TAX	178.90	151.50	18.09	271.30	404.30	-32.90	503.30	4068.50	-87.63
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PAT	8886.30	12130.10	-26.74	12692.70	22248.10	-42.95	16907.20	-999.90	-1790.89
Equity	2399.30	2399.30	0.00	2399.30	2399.30	0.00	2399.30	2399.30	0.00
PBIDTM(%)	29.29	32.26	-9.19	27.24	31.35	-13.10	32.44	24.80	30.81